文献速递乳腺PET

分子乳腺成像检出的乳腺病灶:影响判读的生理参数

Breast Lesions Detected via Molecular Breast Imaging: Physiological Parameters Affecting Interpretation.
PubMed 文献 · Acad Radiol · 2018-03-23

回顾153例女性193个MBI阳性可疑病灶,评估病灶形态、背景实质摄取与乳腺密度同阳性预测值的关系。肿块与非肿块、均匀与不均匀背景摄取的PPV3无显著差异;非致密乳腺活检PPV3高于致密乳腺(85.4% vs 60.6%,P=0.0025)。

要点

  • 肿块与非肿块MBI阳性病灶的PPV3无显著差异(71.7% vs 61.3%,P=0.0717)。
  • 非致密乳腺活检PPV3高于致密乳腺(85.4% vs 60.6%,P=0.0025)。
  • 均匀与不均匀背景摄取的PPV3无显著差异(72.5% vs 60.7%,P=0.103)。

核心结论

  • 肿块或非肿块MBI阳性表现及背景实质摄取变异均不是恶性肿瘤概率的显著决定因素;致密乳腺与较低可预测性及MBI上不均匀背景实质摄取相关。

研究设计与样本

  • 回顾性研究,纳入153例女性(31-81岁)的193个MBI阳性可疑病灶,采用MBI检查,以活检病理为参考标准。

关键影像表现/征象

  • MBI病灶按形态分为肿块与非肿块,肿块表现与更高的癌症怀疑度相关(P<.001)。
  • 致密乳腺与不均匀背景实质摄取有更强关联(P=0.0844)。

诊断标准与关键数值

  • 患者水平PPV1为71.9%(110/153)。
  • 病灶水平PPV3为67.4%(130/193)。
  • 肿块 vs 非肿块活检PPV3为71.7% vs 61.3%(P=.0717)。
  • 均匀 vs 不均匀背景摄取活检PPV3为72.5% vs 60.7%(P=.103)。
  • 非致密 vs 致密乳腺活检PPV3为85.4% vs 60.6%(P=.0025);患者水平PPV1为87.8% vs 66.0%(P=.00844)。

临床应用与阅片要点

  • 判读MBI时,肿块与非肿块表现以及背景实质摄取均匀与否对恶性概率的区分有限。
  • 致密乳腺背景下MBI阳性病灶的恶性预测值较低,报告时需结合乳腺密度综合评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To evaluate correlations between molecular breast imaging (MBI) descriptor characteristics and positive predictive value (PPV) in detecting breast cancer.

MATERIALS AND METHODS: A retrospective review was performed on 193 suspicious findings from 153 women (31-81 years) with positive MBI examinations. We assessed associations between (i) lesion pattern (mass vs. nonmass) and PPV; (ii) lesion pattern and suspected likelihood of cancer (low vs. moderate vs. high); (iii) background parenchymal uptake (BPU) (homogeneous vs. heterogeneous) and PPV; (iv) breast density (dense vs. non-dense) and PPV; and (v) BPU and density.

RESULTS: One hundred ten of 153 patients were diagnosed with malignancy or high-risk pathology (PPV1 = 71.9%), and 130/193 biopsies resulted in malignant or high-risk lesions (PPV3 = 67.4%). Biopsies of mass vs. nonmass findings had comparable PPV3 (71.7% vs. 61.3%; P = .0717). Mass findings were correlated with higher suspicion for cancer than nonmass findings (P < .001). There was no significant difference in PPV3 when comparing biopsies from homogeneous vs. heterogeneous BPU (72.5% vs. 60.7%; P = .103). No association was found between patients' BPU and diagnosed cancer or high-risk lesions (P = .513). Biopsies from nondense breasts demonstrated higher PPV3 than biopsies from dense breasts (85.4% vs. 60.6%; P = .0025); patients with nondense breasts were more likely to be diagnosed with cancer or high-risk pathology (PPV1 = 87.8% vs. 66.0%; P = .00844). Dense breasts had a greater association with heterogeneous BPU (P = .0844).

CONCLUSION: Neither variability in mass or nonmass positive MBI findings, nor variability in BPU on MBI were significant determinants for the probability of malignancy. Dense breasts were associated with lower predictability and heterogeneous BPU on MBI.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Ching JG, Brem RF. Breast Lesions Detected via Molecular Breast Imaging: Physiological Parameters Affecting Interpretation. Acad Radiol. 2018. PMID: 29580791. doi:10.1016/j.acra.2018.03.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。